Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus versus temozolomide chemoradiation in newly diagnosed MGMT-unmethylated glioblastoma
2008-003003-31Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus, temozolomide in glioblastoma (GBM), sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 2009; status: completed.
02
Drugs
temsirolimustemozolomide
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2008-003003-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003003-31.